The U.S. Food and Drug Administration approved the extended use of Sanofi and Regeneron's blockbuster drug Dupixent for ...

From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new targeted drug for the inflammatory skin disease in over a decade, drugmakers ...

The Food and Drug Administration on Thursday cleared a core component of a brain implant made by Precision Neuroscience, a ...

Color additives have faced increased scrutiny since the FDA banned Red Dye No. 3, citing concerns over its links to cancer.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Bausch Health Companies (BHC) and its gastroenterology business, Salix Pharmaceuticals, announced the U.S. District Court for the District of ...

The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...

Can-Fite BioPharma (CANF) announced that leading Medical Centers in the US are approaching the FDA, asking for compassionate use approval to ...

Precision Neuroscience announced that a core component of its brain implant system has been approved by the FDA.

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...